About FDA

July: CBER's Direct Recall Classification Program

DATE: July 25, 2013
TIME: 2:00pm EDT
LENGTH: 30 minutes


Do you know the vital role that FDA plays in product recalls and how the Direct Recall Classification program gets recall information to consumers in a more timely manner?

Consumers are impacted by FDA-regulated products every day. Conducting a recall is an effective way for a firm to remove or correct a violative, and possibly dangerous, product from the market. FDA advises firms on their recall strategies and monitors their recall to determine whether it is effective. FDA also publicizes recalls so consumers and health professionals can find out what types of products are being recalled.

On Thursday, July 25th, FDA hosted a webinar that explains the Direct Recall Classification (DRC) program and its importance to consumers. Laura Hieronymus, Senior Recall Coordinator with the Office of Compliance and Biologics Quality in FDA’s Center for Biologics Evaluation and Research, discussed the importance of timely recall information for consumers and the impact DRC has had on speeding up the information flow between industry and FDA.

After the presentation, there was an opportunity to ask questions.

Webinar Slides: CBER’s Direct Recall Classification Program

View an archived version of the presentation: https://collaboration.fda.gov/p24kew6aosb/

Page Last Updated: 07/27/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English